DNA Diagnostics Market to 2025 (9.8% CAGR Expected) Top Player Profiles – Roche Diagnostics, Bayer Diagnostic, Sysmex, Abbott laboratories, Gene-probe Inc., Cephide, Illumina, Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Johnson and Johnson and

DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. It is also used for clinical diagnostic confirmation and in prenatal diagnostics. The concept of DNA diagnostics has evolved via the breakthrough human genome project that resulted in the discovery of various disease-causing agents. The DNA diagnostics market is expected to generate 19 billion by 2020, growing at a CAGR of 9.8% during the analysis period. Technological development has played a major role in improving DNA diagnostic platforms and techniques.

Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/22842?utm_source=OPR&utm_medium=Anil

Some of the significant technologies which incorporate DNA diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry; these technologies are used for sample preparation, DNA isolation etc. Technological developments, which have led to improvements in these methodologies, drive the growth of the DNA diagnostics market. The use of DNA diagnostic methods in prenatal diagnostics and clinical confirmation has also boosted market growth. The DNA diagnostics market is expected to experience a growth spurt in the foreseeable future. Innovations in product design and technology have prompted doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. The increased adoption of the personalized medicines approach would positively impact the DNA diagnostics market in the foreseeable future. Next generation sequencing is a powerful tool for decoding a number of human diseases, including various forms of cancer. Next generation sequencing reduces the cost of sequencing and increases the throughput. The optimization of sequencing technology could greatly impact the DNA diagnostics market.

The report breaks the market into segments based on product type, technology, application, end users and geography. Based on product types, the market is segmented into instruments, reagents and service & software. The instruments segment holds the dominant share in the market, due to improved healthcare facilities, availability of user-friendly instruments, its competitive cost structure, reliability, size and the growing demand for it in the DNA diagnostics market. However, the service & software segment is expected to grow at a steady rate in the near future due to technological advancements and the incorporation of information technology in the DNA diagnostics market. There are several technologies used in the DNA diagnostics market; these include PCR, mass spectrometry, sequencing technology, in-situ hybridization and microarrays. PCR holds the dominant share due to its frequent usage in diagnostic procedures such as sample preparation, separation and isolation of DNA from collected samples. The DNA diagnostics market is also segmented based on its application in various diseases such as oncology, infectious diseases and myogenic disorders. The oncology segment leads the market and is followed by infectious diseases due to the rising incidence of these diseases and growing elderly population. In terms of geography, the market is segmented into North America, Asia Pacific, Europe and LAMEA. North America holds the dominant share in the market due to the increased adoption of the DNA diagnostics technology and the high prevalence of chronic and infectious diseases. Companies profiled in the report include Roche Diagnostics, Bayer Diagnostic, Sysmex, Abbott laboratories, Gene-probe Inc., Cephide, Illumina, Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Johnson and Johnson, and Novartis.

Get a discount on this research report @ https://www.bigmarketresearch.com/request-for-discount/22842?utm_source=OPR&utm_medium=Anil

Table of Content :
CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Reason for doing the study
1.2.1 Key Benefits
1.2.2 Key Market Segments
1.2.3 Key Audiences
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Application of biotechnology in DNA Diagnostic
3.3 Responsibility of Next-generation Sequencing technologies
3.4 Key Findings
3.4.1 Top Factors Impacting on DNA Diagnostics market
3.4.2 Top Investment Pockets of DNA Diagnostics market
3.4.3 Top winning strategies of DNA Diagnostics market
3.5 Government Regulations
3.5.1 FDA guidelines for personalized medicines
3.6 P orter’s Five force Analysis
3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of Buyers
3.6.3 Threat from new entrants
3.6.4 Threat of Substitute
3.6.5 Competitive Rivalry
3.7 Value chain analysis
3.7.1 Primary Activities
3.7.2 Supportive activities
3.8 Clinical Trials
3.9 Patent Analysis
3.9.1 Patent analysis by geographies(2010-2014)
3.9.2 Patent analysis by sub-segment (2010-2014)
3.10 Market Share Analysis,2013
3.11 Market Dynamics
3.11.1 Drivers
3.11.1.1 Increasing incidences of chronic and infectious diseases
3.11.1.2 Technological Advancements and product modification
3.11.1.3 Increase in popularity personalized medicine approach
3.11.2 Restraints
3.11.2.1 High cost involved in reaseach & development
3.11.2.2 Unclear reimbursement policies&stringent government regulation
3.11.3 Opportunities
3.11.3.1 Technological Development
3.11.3.2 Increasing need of Personalized Medicines
CHAPTER 4 GLOBAL DNA DIAGNOSTICS MARKET BY PRODUCT TYPES
4.1 Instruments
4.1.1 Key market trends
4.1.2 Competitive Scenario
4.1.3 Key growth factors and opportunities
4.1.4 Market size and forecast
4.2 Reagents
4.2.1 Key market trends
4.2.2 Competitive Scenario
4.2.1 Key growth factors and opportunities
4.2.2 Market size and forecast
4.3 Software & Services
4.3.1 Key market trends
4.3.1 Competitive Scenario
4.3.1 Key growth factors and opportunities
4.3.2 Market size and forecast

Inquiry before Buy @ https://www.bigmarketresearch.com/purchase-enquiry/22842?utm_source=OPR&utm_medium=Anil

About Us:
Industry executives tend to keep a tab on their business competitors. This keeps them updated on strategic business activities and investment trends. Company profiles are crucial to participating players of interconnected verticals.

Contact Us:
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Call answer Direct: +1-971-202-1575
Call answer Toll Free: +1-800-910-6452
Email help@bigmarketresearch.com

This release was published on openPR.